Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -2.20% | 128.34 | 0.0% | $1287.67m | |
| OCGN | Ocugen, Inc. | -18.12% | 8.57 | 0.0% | $1027.42m | |
| NVAX | Novavax, Inc. | -18.78% | 149.13 | 92.9% | $585.78m | |
| AMGN | Amgen, Inc. | -0.93% | 221.86 | 1.3% | $543.86m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.80% | 206.77 | 1.9% | $514.71m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.42% | 444.84 | 2.7% | $501.06m | |
| GILD | Gilead Sciences, Inc. | 1.12% | 63.45 | 1.0% | $485.42m | |
| ILMN | Illumina, Inc. | -4.23% | 398.80 | 3.5% | $456.33m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.41% | 147.58 | 2.0% | $340.12m | |
| BIIB | Biogen, Inc. | -0.86% | 264.32 | 1.7% | $317.68m | |
| CRSP | CRISPR Therapeutics AG | -6.08% | 111.84 | 0.6% | $265.73m | |
| BNGO | Bionano Genomics, Inc. | -21.64% | 6.70 | 0.0% | $236.95m | |
| EXAS | EXACT Sciences Corp. | -6.30% | 118.60 | 18.4% | $221.18m | |
| SGEN | Seagen Inc. | -1.87% | 145.17 | 5.8% | $205.12m | |
| PACB | Pacific Biosciences of California, Inc. | -8.32% | 28.39 | 7.2% | $150.20m |
Company Profile
Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. The company was founded on February 10, 1998 and is headquartered in Cardiff, CA.